Katalin Karikó’s neurosurgery department chair kept asking her about hitting his preferred metric of “dollars per net square footage,” in terms of funding her lab time with grants, or even prestigious publication. It’s amusingly anodyne and corporate when recounted by a now eminent scientist, who had just told her boss about beginning to collaborate with a cross-disciplinary immunologist Drew Weissman, with whom she would later share the Nobel Prize.
That’s from Breaking Through: My Life in Science, the October 2024 autobiography by biochemist Katalin Karikó, who shared the 2023 Nobel Prize in medicine for her work on mRNA which contributed to the rapid deployment of the covid-19 vaccine. I admire her greatly.
In an over-simplification, cell and gene therapies directly influence DNA, whereas her research focused on using mRNA to send a temporary message to cells. mRNA is considered more unstable and difficult to work on, so it had long been dismissed as not an effective means of treatment. She’s become a canonical example of a delayed payoff for hyper-fixation on a particular problem (almost 20 years with limited academic or industry recognition).
The autobiography is an enjoyable read, starting with her being raised in Soviet Hungary. She criticizes the surveillance system, but remembers fondly its elevation of science and spotting kids with promise from households with less education. She remembers that her school transcripts always had an “F”, for “fizkai” to clarify her parents had worked “physical” jobs and were low educated, which got her extra attention from educators in communist Hungary.
She says half of her elite biology college cohort came from this working class tradition: can any elite American institution claim this?
Below I share my notes for future reference.
Continue reading Katalin Karikó on “Breaking Through”